Literature DB >> 16728905

Pain insensitivity in schizophrenia: trait or state marker?

Manpreet K Singh1, Lisa L Giles, Henry A Nasrallah.   

Abstract

OBJECTIVES: As early as the turn of the 20th century, clinicians observed patients with schizophrenia failing to respond to the pain of a myocardial infarction, ruptured appendix, or perforated bowel. Although this pain insensitivity in individuals with psychosis has been described in the literature for many years, the phenomenon is still poorly understood. We therefore reviewed the literature for findings concerning whether pain insensitivity in schizophrenia represents a state or a trait marker.
METHODS: A comprehensive Medline search of the literature on pain insensitivity in subjects with schizophrenia was conducted.
RESULTS: While the literature contains anecdotal observations, case reports, and a few rigorous clinical studies concerning patients with schizophrenia being relatively indifferent to pain, there is a dearth of empirical, well-controlled studies in this area. Although early studies that examined the response of individuals with schizophrenia to thermal or electrical pain were constrained by a variety of methodological confounders, studies on this topic suggest that the higher pain thresholds observed in schizophrenia are best explained by a complex, multifactorial model. Most intriguing are the results of one recent study that found pain insensitivity in family members of persons with schizophrenia, suggesting that this phenomenon may be a trait or endophenotype rather than being due to a psychotic state.
CONCLUSIONS: Pain insensitivity in individuals with schizophrenia, which is associated with increased morbidity and mortality, is poorly understood. It is possible that pain insensitivity might serve as a prodromal predictor of susceptibility for schizophrenia. Future studies are needed to further clarify the neurobiology, pathophysiology, and practical clinical implications of this phenomenon.

Entities:  

Mesh:

Year:  2006        PMID: 16728905     DOI: 10.1097/00131746-200603000-00004

Source DB:  PubMed          Journal:  J Psychiatr Pract        ISSN: 1527-4160            Impact factor:   1.325


  34 in total

1.  Prescription Opioid Use Among Seriously Mentally Ill Veterans Nationally in the Veterans Health Administration.

Authors:  Nickie Mathew; Robert A Rosenheck
Journal:  Community Ment Health J       Date:  2015-09-15

2.  Pain sensitivity is altered in animals after subchronic ketamine treatment.

Authors:  Axel Becker; Gisela Grecksch; Helmut Schröder
Journal:  Psychopharmacology (Berl)       Date:  2006-10-03       Impact factor: 4.530

Review 3.  The Insula and Taste Learning.

Authors:  Adonis Yiannakas; Kobi Rosenblum
Journal:  Front Mol Neurosci       Date:  2017-11-03       Impact factor: 5.639

4.  Involvement of spinal 5-HT1A receptors in isolation rearing-induced hypoalgesia in mice.

Authors:  Naotaka Horiguchi; Yukio Ago; Kazuki Asada; Yuki Kita; Naoki Hiramatsu; Kazuhiro Takuma; Toshio Matsuda
Journal:  Psychopharmacology (Berl)       Date:  2012-12-29       Impact factor: 4.530

5.  Glutamatergic Response to Heat Pain Stress in Schizophrenia.

Authors:  Joshua Chiappelli; Qiaoyun Shi; Sarah Andrea Wijtenburg; Raimi Quiton; Krista Wisner; Frank Gaston; Priyadurga Kodi; Christopher Gaudiot; Peter Kochunov; Laura M Rowland; Liyi Elliot Hong
Journal:  Schizophr Bull       Date:  2018-06-06       Impact factor: 9.306

Review 6.  Pain and analgesia: the value of salience circuits.

Authors:  David Borsook; Robert Edwards; Igor Elman; Lino Becerra; Jon Levine
Journal:  Prog Neurobiol       Date:  2013-03-07       Impact factor: 11.685

7.  Haloperidol and risperidone have specific effects on altered pain sensitivity in the ketamine model of schizophrenia.

Authors:  Axel Becker; Gisela Grecksch; Gerald Zernig; Elisabeth Ladstaetter; Christoph Hiemke; Ulrich Schmitt
Journal:  Psychopharmacology (Berl)       Date:  2008-09-23       Impact factor: 4.530

8.  Lack of insula reactivity to aversive stimuli in schizophrenia.

Authors:  Clas Linnman; Garth Coombs; Donald C Goff; Daphne J Holt
Journal:  Schizophr Res       Date:  2012-11-30       Impact factor: 4.939

9.  Cannabinoid-mediated diversity of antinociceptive efficacy of parecoxib in Wistar and Sprague Dawley rats in the chronic constriction injury model of neuropathic pain.

Authors:  Axel Becker; Gerd Geisslinger; Radovan Murín; Gisela Grecksch; Volker Höllt; Andreas Zimmer; Helmut Schröder
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-02-01       Impact factor: 3.000

10.  Pain reactivity and plasma beta-endorphin in children and adolescents with autistic disorder.

Authors:  Sylvie Tordjman; George M Anderson; Michel Botbol; Sylvie Brailly-Tabard; Fernando Perez-Diaz; Rozenn Graignic; Michèle Carlier; Gérard Schmit; Anne-Catherine Rolland; Olivier Bonnot; Séverine Trabado; Pierre Roubertoux; Guillaume Bronsard
Journal:  PLoS One       Date:  2009-08-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.